Complete Genomics' Shares Soar in April | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Complete Genomics climbed 83 percent in April, after the firm's CEO presented an update on the company's business at a conference and analysts increased their revenue expectations.

Complete Genomics led all shares in the GenomeWeb Daily News Index, which gained 8 percent amid a strong month for the stock market in general, with the Dow Jones Industrial Average up 4 percent, the Nasdaq up 3 percent, and the Nasdaq Biotech Index up 7 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.